Twitter | Search | |
This is the legacy version of twitter.com. We will be shutting it down on 15 December 2020. Please switch to a supported browser or device. You can see a list of supported browsers in our Help Center.
MA Health Policy Commission
Leading efforts to advance MA's ambitious goal of bringing health care spending growth in line with the growth in the state’s economy.
6,111
Tweets
773
Following
3,511
Followers
Tweets
MA Health Policy Commission Nov 18
The C4SEN RFP will be issued today! Learn more here:
Reply Retweet Like
MA Health Policy Commission Nov 18
The selection criteria covers five domains: the applicant, the proposed program, application of a health equity lens, program operations and budget, and sustainability.
Reply Retweet Like
MA Health Policy Commission Nov 18
The HPC has determined the timeframe for the Period of Performance, as well as some defined metrics that awardees will be required to regularly report.
Reply Retweet Like
MA Health Policy Commission Nov 18
The RFP also outlines health equity considerations for applicants.
Reply Retweet Like
MA Health Policy Commission Nov 18
The RFP outlines five required operational components of the proposed models.
Reply Retweet Like
MA Health Policy Commission Nov 18
The HPC plans to invest $1.2 million dollars in the C4SEN Investment Program.
Reply Retweet Like
MA Health Policy Commission Nov 18
The C4SEN Investment Program will have four objectives.
Reply Retweet Like
MA Health Policy Commission Nov 18
COVID-19 has both exacerbated the opioid crisis and created opportunities to improve treatment.
Reply Retweet Like
MA Health Policy Commission Nov 18
This slide visualizes past HPC investments supporting Substance Exposed Newborns (SEN), some of which were administered in partnership with DPH.
Reply Retweet Like
MA Health Policy Commission Nov 18
The HPC is developing robust processes for patients, clinicians, and other experts to provide input during the course of a drug pricing review.
Reply Retweet Like
MA Health Policy Commission Nov 18
This slide summarizes what we expect to be the key inputs to and outputs from a drug pricing review.
Reply Retweet Like
MA Health Policy Commission Nov 18
After being referred from MassHealth, the HPC may identify a proposed value or a supplemental rebate for the drug, determine that the manufacturer's pricing is unreasonable, or close the review.
Reply Retweet Like
MA Health Policy Commission Nov 18
To initiate the review process, negotiates directly with a drug manufacturer. After rounds of negotiation, if necessary, MassHealth refers the manufacturer to the HPC.
Reply Retweet Like
MA Health Policy Commission Nov 18
Providers expressed the most concern about the socioeconomic impacts of COVID-19 on patients and staff through stress and burnout.
Reply Retweet Like
MA Health Policy Commission Nov 18
Some independent primary care practices have either undergone or are considering major changes, such as evolving toward concierge medicine, consolidating with other practices or hospitals, or selling or closing the practice.
Reply Retweet Like
MA Health Policy Commission Nov 18
Many of the staff who were furloughed in all settings were eventually rehired, though this was not the case in BH practices for both clinical and non-clinical staff.
Reply Retweet Like
MA Health Policy Commission Nov 18
brought behavioral health practices back to pre-pandemic visit levels by summer 2020, while visits at all other practices remained roughly 20% below baseline.
Reply Retweet Like
MA Health Policy Commission Nov 18
A research collaboration across faculty from the state’s medical schools in conjunction with HPC, the MA chapter of , and others produced a targeted survey of provider practices on the impacts of COVID-19. Broad themes of responses:
Reply Retweet Like
MA Health Policy Commission Nov 18
While hospitals sustained losses in March and April, COVID-19 relief funds led to large positive margins in June (12%) and July (22%).
Reply Retweet Like
MA Health Policy Commission Nov 18
Black and Hispanic patients accounted for 38.3% of COVID-related inpatient discharges from April to June 2020, compared to 20.5% of non-COVID discharges.
Reply Retweet Like